Research

More Research Stories

Vaccine technology developed by OHSU scientists acquired by industry leaders

By Ariane Le Chevallier January 25, 2017
A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.

New research provides key insight about mitochondrial replacement therapy

By Erik Robinson November 30, 2016
A new discovery may unlock the answer to a vexing scientific question: How to conduct mitochondrial replacement therapy, a new gene-therapy technique, in such a way that safely prevents the transmission of harmful mitochondrial gene mutations from mothers to their children.

Kill the cancer, protect the brain

By Erik Robinson November 28, 2016
When the possibility of death is the only alternative, most people will opt for the most aggressive cancer treatments possible. The problem is, a new study by researchers at OHSU suggests that a robust combination of therapies that are effective in targeting the cancer can lead to harmful cognitive effects in the brain if the patient survives.

Study: Enhancing cancer response to radiation

By Amanda Gibbs November 28, 2016
OHSU researcher Sudarshan Anand, Ph.D., has a contemporary analogy to describe microRNA: “I sometimes compare MicroRNA to tweets — they’re short, transient and constantly changing.”
See more stories